CD79A and myeloid sarcoma: More significant to this review’s context, IgA produced by B cells that cross-react with gut microbes have been identified in the CNS of MS patients with active lesions (80) and regulate neuroinflammation through IL-10 production (81), highlighting the importance of B cells on the gut-microbiota-brain axis.